Matthew P. Miller - Mar 21, 2022 Form 4/A - Amendment Insider Report for Oncology Institute, Inc. (TOI)

Role
Chief Operating Officer
Signature
/s/ Mark Hueppelsheuser, Attorney-in-Fact for Matthew P Miller
Stock symbol
TOI
Transactions as of
Mar 21, 2022
Transactions value $
$0
Form type
4/A - Amendment
Date filed
3/29/2022, 08:11 PM
Date Of Original Report
Mar 23, 2022
Previous filing
Mar 23, 2022
Next filing
Nov 22, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TOI Stock Option (right to buy) Award $0 +32.4K $0.00 32.4K Mar 21, 2022 Common stock 32.4K $7.09 Direct F1
transaction TOI Stock Option (right to buy) Award $0 +110K $0.00 110K Mar 21, 2022 Common stock 110K $7.09 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options vest in four equal annual installments on each of the first four anniversaries of November 12, 2021 (the "Vesting Commencement Date"), with all options becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.
F2 The stock options vest as to 1/3rd of the options granted on the second anniversary of the Vesting Commencement Date, with the remaining options vesting in four equal annual installments beginning on the third anniversary of the Vesting Commencement Date, with all options becoming vested on the sixth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.

Remarks:

This amendment is filed to correct the number of options granted due to an administrative error in applying the grant amount calculations.